Canaccord Genuity Group Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $2.25

Bioceres Crop Solutions (NASDAQ:BIOXFree Report) had its price target decreased by Canaccord Genuity Group from $2.50 to $2.25 in a report issued on Friday,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock.

Several other research analysts also recently weighed in on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Bioceres Crop Solutions in a report on Wednesday, October 8th. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Oppenheimer lowered Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, October 22nd. Brookline Capital Management cut Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 21st. Finally, Lake Street Capital cut their price objective on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $4.08.

Read Our Latest Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $1.68 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.91 and a quick ratio of 0.62. The firm has a market cap of $106.23 million, a PE ratio of -2.00 and a beta of 0.41. The firm has a 50 day simple moving average of $1.74 and a 200-day simple moving average of $3.23. Bioceres Crop Solutions has a 1-year low of $1.20 and a 1-year high of $7.44.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several institutional investors and hedge funds have recently modified their holdings of BIOX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Bioceres Crop Solutions by 9.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock worth $3,761,000 after acquiring an additional 71,581 shares in the last quarter. Allianz Asset Management GmbH raised its stake in shares of Bioceres Crop Solutions by 77.5% during the first quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company’s stock valued at $1,081,000 after purchasing an additional 103,337 shares during the period. Fourth Sail Capital LP lifted its position in shares of Bioceres Crop Solutions by 25.1% during the first quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company’s stock worth $21,125,000 after purchasing an additional 928,708 shares in the last quarter. Long Focus Capital Management LLC boosted its stake in shares of Bioceres Crop Solutions by 11.4% in the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company’s stock valued at $3,788,000 after purchasing an additional 85,000 shares during the period. Finally, Walleye Capital LLC acquired a new stake in Bioceres Crop Solutions during the 1st quarter valued at $199,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Read More

Analyst Recommendations for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.